金莲花颗粒联合布地奈德治疗急性咽炎疗效观察及对炎症因子水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R766.14

基金项目:


Clinical Effect of Jinlianhua Granules Combined with Budesonide on Acute Pharyngitis and Its Effect on Levels of Inflammatory Factors
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察金莲花颗粒联合布地奈德治疗急性咽炎的临床疗效及对血清炎症因子水平的影响。方 法:对90 例急性咽炎进行回顾性分析,根据治疗方式的不同将其分为对照组和观察组各45 例。对照组给予吸 入用布地奈德混悬液治疗,观察组在对照组的基础上加用金莲花颗粒治疗。比较2 组临床疗效、症状缓解时 间、不良反应发生率,以及治疗前后中医证候评分、血清炎症因子[白细胞介素-6 (IL-6)、肿瘤坏死因 子-α (TNF-α)、超敏C-反应蛋白(hs-CRP)] 水平。结果: 观察组总有效率为91.11%, 对照组为 82.22%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组咽痛、咽干灼热、黏膜充血、发热、微恶 寒、咳嗽痰黄等中医证候评分比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项中医证候评分均较 治疗前降低(P<0.05),且观察组各项评分均低于对照组(P<0.05)。治疗后,观察组咽痛、咽干、咽部灼热 症状缓解时间均短于对照组,差异有统计学意义(P<0.05)。治疗前,2 组血清IL-6、hs-CRP、TNF-α 水平 比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项炎症因子水平均较治疗前降低(P<0.05),且观 察组3 项指标均低于对照组(P<0.05)。观察组不良反应发生率为8.88%,对照组为17.77%,2 组比较,差异 有统计学意义(P<0.05)。结论:金莲花颗粒联合布地奈德治疗急性咽炎可提高疗效,有效抑制机体炎症反 应,降低中医证候评分和不良反应发生率,加速病情康复,且安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Jinlianhua Granules combined with Budesonide on acute pharyngitis and its effect on levels of inflammatory factors in serum. Methods:A total of 90 cases of patients with acute pharyngitis were given retrospective analysis and divided into the control group and the observation group according to their different treatment methods, with 45 cases in each group. The control group was treated with Budesonide Suspension for Inhalation, and the observation group was additionally treated with Jinlianhua Granules based on the treatment of the control group. The traditional Chinese medicine (TCM) syndrome scores and levels of inflammatory factors in serum [C- reactive protein (CRP),interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) ] before and after treatment,as well as the clinical effects,relief time of symptoms,and incidence of adverse reactions were compared between the two groups. Results:The total effective rate was 91.11% in the observation group and 82.22% in the control group, the difference being significant (P<0.05). Before treatment, there was no significant difference being found in the comparison of TCM syndrome scores including pharyngalgia, dryness and scorching of the pharynx, mucous hyperemia, fever, mild aversion to cold, and cough and yellow sputum between the two groups (P>0.05);after treatment,the above TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05), and the scores in the observation group were lower than those in the control group (P<0.05). The relief time of symptoms including pharyngalgia,dryness and scorching of the pharynx in the observation group was shorter than that in the control group,the difference being significant (P<0.05). Before treatment,there was no significant difference being found in the comparison of levels of IL-6,hs-CRP and TNF-α in serum between the two groups (P>0.05); after treatment, the above levels of inflammatory factors in the two groups were decreased when compared with those before treatment (P<0.05),and the 3 indexes in the observation group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 8.88% in the observation group and 17.77% in the control group, the difference being significant (P<0.05). Conclusion: Jinlianhua Granules combined with Budesonide can improve curative effect for acute pharyngitis, effectively inhibit inflammatory responses in the body, reduce TCM syndrome scores and incidence of adverse reactions,and accelerate the rehabilitation of the disease with high safety.

    参考文献
    相似文献
    引证文献
引用本文

徐开睿,黄武,章誉耀.金莲花颗粒联合布地奈德治疗急性咽炎疗效观察及对炎症因子水平的影响[J].新中医,2023,55(10):91-95

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-25
  • 出版日期:
文章二维码